Review

PD-1, PD-L1 mechanism and cancer treatment

Aslı Babayakalı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.019
2325 2209

Neurotransmitters and hair loss

Aylin Kayaaltı, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.020
4062 12826

RIPK1 and obesity-induced inflammation

Aslı Melike Ekmekçi, Fehmi Balandi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.021
2616 1962

Terazosin and neuroprotection

Ayşe Yürekli, Atakan Ölçenoğlu, Manolya Yıldız, Begüm Arda, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.022
4499 2331

Tumor markers and clinical use

Burak Akverdi, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.023
5859 6930

Alkaliptosis: A new strategy for cancer therapy

Beyza Emine Kılınç, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.024
3624 2688

Subgenual anterior cingulate cortex and psychiatric disorders

Berfin Sıla Akdoğdu, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.025
5022 1937

Bone marrow transplantation use on treatment solid tumors

İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.026
2567 2148

Superparamagnetic iron oxide nanoparticles use in the temporal lobe epilepsy model

Özge Çağlar, Elif Özyılmaz, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.027
2398 1966

Effect of mitochondrial dysfunction and oxidative stress on the pathogenesis of autism spectrum disorders

Umut Yücel, İrem Kahramanoğlu, İlknur Altuntaş, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.028
5472 2489

Cancer cells and alpha-ketoglutarate

Yalda Sadeghian, İlayda Üzümcü, Oytun Erbaş

DOI: 10.5606/dsufnjt.2021.029
3628 2851